Krishna Institute of Medical Sciences Ltd

AI
Krishna Institu. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Krishna Institute of Medical Sciences Ltd

₹ 670 0.67%
26 Oct - close price
kimshospitals.com BSE: 543308 NSE: KIMS
About

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

Key Points

Regional Leadership
KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and AP, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The Group offers healthcare services in specialties and super specialties across more than 40 fields. [1]

Website BSE NSE
  • Market Cap ₹ 28,124 Cr.
  • Current Price ₹ 670
  • High / Low ₹ 858 / 576
  • Stock P/E 103
  • Book Value ₹ 60.7
  • Dividend Yield 0.00 %
  • ROCE 13.0 %
  • ROE 11.5 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 11.0 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 12.7% over last 3 years.
  • Promoter holding has decreased over last 3 years: -6.20%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 Nifty Healthcare Index BSE Healthcare Nifty 500 BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
299 316 302 305 327 363 348 346 373 430 442 456 484
207 218 215 218 234 252 245 237 276 318 314 326 365
Operating Profit 92 98 87 86 94 111 103 109 98 112 128 130 118
OPM % 31% 31% 29% 28% 29% 31% 30% 31% 26% 26% 29% 29% 24%
4 4 4 4 5 7 21 35 12 12 14 11 31
Interest 0 0 1 2 4 5 7 8 12 18 22 27 33
Depreciation 12 13 13 20 14 14 15 15 18 20 23 26 27
Profit before tax 84 89 78 68 82 99 102 120 80 86 98 89 89
Tax % 25% 26% 25% 29% 26% 27% 25% 22% 26% 26% 26% 26% 25%
63 66 58 48 61 72 76 94 59 64 72 66 66
EPS in Rs 1.56 1.65 1.46 1.20 1.52 1.80 1.91 2.34 1.47 1.59 1.81 1.65 1.58
Raw PDF
Upcoming result date: 4 November 2026

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
485 536 628 707 790 933 1,143 1,132 1,222 1,384 1,702 1,812
380 422 562 652 584 624 740 768 857 963 1,229 1,323
Operating Profit 104 114 66 55 206 309 403 364 366 421 473 489
OPM % 22% 21% 10% 8% 26% 33% 35% 32% 30% 30% 28% 27%
4 3 3 6 7 8 21 23 18 68 50 68
Interest 36 32 88 33 24 18 9 5 7 28 84 99
Depreciation 34 34 38 41 43 45 45 45 58 58 86 96
Profit before tax 38 51 -57 -13 147 254 371 337 318 403 353 362
Tax % 37% 37% 43% 225% 17% 26% 25% 25% 26% 25% 26%
24 33 -81 -44 121 189 278 252 235 303 261 268
EPS in Rs 0.69 0.91 -2.27 -1.17 3.25 4.86 6.96 6.31 5.88 7.57 6.52 6.63
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 13%
5 Years: 13%
3 Years: 15%
TTM: 27%
Compounded Profit Growth
10 Years: 27%
5 Years: 7%
3 Years: 2%
TTM: -7%
Stock Price CAGR
10 Years: %
5 Years: 24%
3 Years: 21%
1 Year: -7%
Return on Equity
10 Years: 14%
5 Years: 15%
3 Years: 13%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 70 72 50 74 74 78 80 80 80 80 80
Reserves 191 252 -249 429 550 830 1,298 1,551 1,786 2,088 2,349
251 277 666 187 186 131 18 4 326 708 1,526
134 153 323 166 147 175 173 177 204 313 330
Total Liabilities 646 753 789 857 957 1,214 1,569 1,812 2,397 3,189 4,285
498 501 576 567 559 582 592 612 674 773 1,534
CWIP 2 64 0 0 2 8 13 16 292 530 116
Investments 18 22 31 80 178 213 542 826 1,062 1,226 1,523
128 167 182 210 218 411 422 358 368 660 1,113
Total Assets 646 753 789 857 957 1,214 1,569 1,812 2,397 3,189 4,285

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
89 78 94 109 161 291 284 271 262 294 292
-39 -99 -52 -99 -108 -317 -375 -238 -569 -627 -956
-61 25 -42 -12 -24 25 76 -15 289 339 662
Net Cash Flow -10 5 0 -2 28 0 -15 18 -18 6 -1
Free Cash Flow 57 -20 50 63 140 219 215 150 -58 -12 -63
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 85% 79% 176% 245% 101% 108% 94% 95% 95% 91% 79%

Ratios

Standalone / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 46 59 56 52 46 29 28 39 44 49 60
Inventory Days 35 43 39 42 44 30 38
Days Payable 192 205 189 161 158 155 118
Cash Conversion Cycle -111 -103 -94 -68 -68 -96 -52 39 44 49 60
Working Capital Days 11 26 -72 2 -4 -29 6 12 3 -23 -35
ROCE % 15% 6% 3% 23% 30% 31% 23% 17% 16% 13%

Insights

In beta
Mar 2015 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
ARPOB (Average Revenue Per Occupied Bed)
Rs

Log in to view insights

Please log in to see hidden values.

Login
Bed Occupancy
%
Total Bed Capacity
Beds
ALOS (Average Length of Stay)
Days
IP Volume (Inpatient Volume)
Patients
OP Volume (Outpatient Volume)
Patients
Operational Beds
Beds
ARPP (Average Revenue Per Patient)
Rs
Specialty Mix - Cardiac Sciences
% of revenue

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
38.82% 38.82% 38.82% 38.82% 38.82% 38.82% 34.11% 34.11% 34.11% 34.11% 32.49% 32.65%
15.27% 16.73% 17.84% 15.85% 15.68% 15.44% 15.54% 15.03% 14.33% 14.57% 14.75% 15.01%
34.24% 33.13% 32.12% 32.29% 32.05% 31.95% 31.65% 32.12% 32.72% 32.50% 34.42% 33.22%
11.67% 11.32% 11.22% 13.03% 13.45% 13.78% 18.68% 18.74% 18.85% 18.82% 18.32% 19.10%
No. of Shareholders 71,01469,09269,06377,61795,4681,01,8951,08,9551,04,8721,01,59993,33394,73095,609

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls